In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier. (2019)
Attributed to:
A new noradrenergic strategy to treat Impulsivity in Progressive Supranuclear Palsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.35731
Publication URI: https://www.repository.cam.ac.uk/handle/1810/288443
Type: Journal Article/Review